1-11 of 11
Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Medical Industry FeatureInsights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Jennifer Caudle, DO, FACOFP
Felicia Cosman, MD
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
Medical Industry FeatureResearch Uncovers a Potential Biomarker for Postpartum Depression Risk
Lauren Osborne, M.D.
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry FeatureLatest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Komal Jhaveri, MD, FACP
Vanessa Soto-Romano
Postpartum Depression: A Common Yet Overlooked Condition
Medical Industry FeaturePostpartum Depression: A Common Yet Overlooked Condition
Sarah Oreck, MD
Brooke Kyle, MD
MIRASOL Insights in PROC: A Biomarker-Driven Approach
Project Oncology®MIRASOL Insights in PROC: A Biomarker-Driven Approach
Charles Turck, PharmD, BCPS, BCCCP
Cecelia Boardman, MD
New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Medical Industry FeatureNew 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Tamatha Fenster, M.D., M.S.
- advertisement
Freeze-All Policy: Is It Right for Everyone?
Global Women's Health AcademyFreeze-All Policy: Is It Right for Everyone?
Matheus Roque, M.D.
What is the POSEIDON Classification?
Global Women's Health AcademyWhat is the POSEIDON Classification?
Peter Humaidan, MD
Nikolaos P. Polyzos, MD
Impact of COS: Gonadotropics and Ovulation Trigger on Oocyte Competence
Global Women's Health AcademyImpact of COS: Gonadotropics and Ovulation Trigger on Oocyte Competence
Peter Humaidan, MD
LH vs hCG: Formulations and Physiological Differences
Global Women's Health AcademyLH vs hCG: Formulations and Physiological Differences
Sandro Esteves, MD, PhD
- advertisement
